National Institute of Allergy and Infectious Diseases – Startup Investor Profile

National Institute of Allergy and Infectious is a medical research agency that supports basic and applied research for allergic diseases.

Location: Bethesda

Country:

Investment Regions:

Investment Stages:

Website: https://www.niaid.nih.gov/

AI Reasoning: Searches on NIAID site and news show multiple grant awards through mid-2025 (e.g., MiNK Therapeutics awarded NIAID grant on Jun 2, 2025), but no evidence of NIAID making an investment or grant to a startup within the past 6 months prior to the reference date. The most recent identified award to a company (MiNK Therapeutics) occurred on Jun 2, 2025, which is more than 4 months before the reference date; however, classification thresholds: less than 3 months = very-active, 3-6 months = active, 6-12 = low-active, >12 = not-active. Since Jun 2, 2025 is 5 months before the reference date, that places it in the active category. But given majority of NIAID activity are grants posted in March-June 2025 and the most recent corporate award found is Jun 2, 2025 (to MiNK Therapeutics), the correct tag is active.

Not Active – No known investments in the last 12 months.

Low Activity – Only known investments between the last 12 and 6 months.

Active – Known investments between the last 6 and 3 months.

Very Active – Known investments in the last 3 months.